202 results on '"Ghinea, Narcyz"'
Search Results
2. Access to high cost cancer medicines through the lens of an Australian Senate Inquiry - defining the 'Goods' at stake
3. Consumer perspectives of accelerated access to medicines: a qualitative study
4. A survey of Australian public attitudes towards funding of high cost cancer medicines
5. The Oversight of Clinical Innovation in a Medical Marketplace
6. The increasing costs of medicines and their implications for patients, physicians and the health system.
7. Clinicians’ Perspective on Implementing Virtual Hospital Care for Low Back Pain: Qualitative Study
8. The incidence of personal importation of prescription medicines among Australians 45 and older: a cross-sectional survey
9. The Medicines Repurposing Program – a critical perspective.
10. An ethical framework for the creation, governance and evaluation of accelerated access programs
11. What about the reasonableness of patients’ risk attitudes? A challenge to Makins’ antipaternalistic account
12. Lead Essay: Money, Equity and Access to Medicines
13. How therapeutic advances have transformed the medical landscape: a primer for clinicians
14. ‘First ensure no regret’: a decision-theoretic approach to informed consent in clinical practice
15. Clinicians’ Perspective on Implementing Virtual Hospital Care for Low Back Pain: Qualitative Study (Preprint)
16. Clinical Quandaries Associated With Accelerated Access to Medicines
17. Off-Label Prescribing
18. Physicians’ legal duty to disclose more cost-effective treatment options: an examination of Australian civil law applied to personal importation
19. Promoting the personal importation of therapeutic goods: recent legislative amendments to advertising regulations may impact consumer access and understanding
20. Negotiating limits to the funding of high cost cancer medicines
21. Accelerated Access to Medicines: An Ethical Analysis
22. Ethics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VII
23. Caution needed in introduction of provisional approvals for medicines
24. Demands for access to new therapies: are there alternatives to accelerated access?
25. Ethics Consultation Services as a Resource and its Implications for Evaluation Activities
26. Do doctors have a responsibility to help patients import medicines from abroad?
27. x?
28. The Ethics Around Drug Labels and Generic Medicines
29. Situating commercialization of assisted reproduction in its socio-political context: a critical interpretive synthesis
30. The oversight of clinical innovation in a medical marketplace
31. Propaganda or the cost of innovation? Challenging the high price of new drugs
32. Personal Importation and the Law: Protecting Patients Who Import Medicines for Legitimate Health Care Needs.
33. Do doctors have a responsibility to help patients import medicines from abroad?
34. Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage
35. Evidence, regulation and ‘rational’ prescribing: the case of gabapentin for neuropathic pain
36. Regulating autologous stem cell interventions in Australia: updated review of the direct-to-consumer advertising restrictions
37. Referee report. For: The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world? [version 1; peer review: 1 approved, 1 approved with reservations]
38. Is it ethical to prescribe paracetamol for acute low back pain and osteoarthritis?
39. Death, dying and donation: community perceptions of brain death and their relationship to decisions regarding withdrawal of vital organ support and organ donation
40. Emergency department care for low back pain: Should we adopt recommendations from primary care guidelines?
41. Are my religious beliefs anyone’s business? A framework for declarations in health and biomedicine
42. A return to reasonableness and virtue in medical epistemology
43. Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics
44. “Some sort of fantasy land”: A qualitative investigation of appropriate prescribing in cancer care
45. Citizen Science and the Politicization of Epistemology
46. Limiting religious contributions – a response to Schuklenk
47. Clarifying the Relationship Between Serious Ethical Violations and Conflicts of Interest
48. ‘Treat them into the grave’: cancer physicians’ attitudes towards the use of high‐cost cancer medicines at the end of life
49. Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries
50. An empirical and normative critique of 'off-label' prescribing as a category of medicines use
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.